Clinical Trial Update: CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for CP4071 in patients with locally advanced or metastatic soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• CP4071

Snippet

Sponsor: Herbert Irving Comprehensive Cancer Center | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN